Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture.

MLA

Svec, Riley L., et al. “Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture.” ACS Chemical Biology, vol. 17, no. 2, Feb. 2022, pp. 299–313. EBSCOhost, https://doi.org/10.1021/acschembio.2c00022.

APA

Svec, R. L., McKee, S. A., Berry, M. R., Kelly, A. M., Fan, T. M., & Hergenrother, P. J. (2022). Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture. ACS Chemical Biology, 17(2), 299–313. https://doi.org/10.1021/acschembio.2c00022

Chicago

Svec, Riley L, Sydney A McKee, Matthew R Berry, Aya M Kelly, Timothy M Fan, and Paul J Hergenrother. 2022. “Novel Imidazotetrazine Evades Known Resistance Mechanisms and Is Effective against Temozolomide-Resistant Brain Cancer in Cell Culture.” ACS Chemical Biology 17 (2): 299–313. doi:10.1021/acschembio.2c00022.